Artificial Intelligence Biotech Sustainability 
N2Growth Blog
JANUARY 10, 2024
Understanding the Unique Challenges of Biotech Leadership Recruitment Organizations face some unique challenges when it comes to leadership recruitment in the biotech space. Navigating these unique challenges in biotech leadership recruitment requires a comprehensive understanding of the industry, its trends, and specific needs.
Crunchbase News
OCTOBER 1, 2024
However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.
TechCrunch
AUGUST 15, 2022
Atarraya , creator of Shrimpbox, a sustainable “plug-and-play” shrimp farming technology, is swimming to the surface after being in stealth mode since 2019. We wanted to make the shrimp business more sustainable and more efficient without destroying the environment,” Russek said. “We million in Series A dollars, and a new U.S.
Crunchbase News
JULY 12, 2024
After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.
Crunchbase News
JUNE 28, 2024
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. EvolutionaryScale , $142M, biotech: It was a big week for biotech. billion, per Crunchbase.
TechCrunch
DECEMBER 2, 2020
Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”
TechCrunch
AUGUST 10, 2022
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” “Prosperity7 inspired us to look into sustainable chemistry,” said Zhavoronkov.
Expert insights. Personalized for you.
97 
Let's personalize your content